These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6629579)

  • 1. Locus of control and initiation of detoxification among male methadone maintenance patients.
    Langrod J; Des Jarlais DC; Alksne L; Lowinson J
    Int J Addict; 1983 Aug; 18(6):783-90. PubMed ID: 6629579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and diagnostic reliability of methadone maintenance detoxification fear.
    Milby JB; Gurwitch RH; Wiebe DJ; Ling W; McLellan AT; Woody GE
    Am J Psychiatry; 1986 Jun; 143(6):739-43. PubMed ID: 3717396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone maintenance outcome as a function of detoxification phobia.
    Milby JB; Hohmann AA; Gentile M; Huggins N; Sims MK; McLellan AT; Woody G; Haas N
    Am J Psychiatry; 1994 Jul; 151(7):1031-7. PubMed ID: 8010360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
    Schütz CG; Rapiti E; Vlahov D; Anthony JC
    Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of methadone maintenance in clinical opiate dependence].
    Gössling HW; Gunkel S; Wegener U; Woiton V
    Fortschr Neurol Psychiatr; 1998 Jun; 66(6):278-85. PubMed ID: 9676423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance to abstinence. How many make it?
    Milby JB
    J Nerv Ment Dis; 1988 Jul; 176(7):409-22. PubMed ID: 3045260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The index of choice: indications of methadone patients' selection of naltrexone treatment.
    Singleton EG; Sherman MF; Bigelow GE
    Am J Drug Alcohol Abuse; 1984; 10(2):209-21. PubMed ID: 6475888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detoxification from methadone maintenance treatment in Sweden: long-term outcome and effects on quality of life and life situation.
    Eklund C; Melin L; Hiltunen A; Borg S
    Int J Addict; 1994 Apr; 29(5):627-45. PubMed ID: 8034376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone maintenance outcome as a function of detoxification fear: preliminary findings.
    Milby JB; Gentile M; Sims MK; McLellan AT; Woody G; Haas N
    NIDA Res Monogr; 1990; 105():589-90. PubMed ID: 1876132
    [No Abstract]   [Full Text] [Related]  

  • 12. Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
    Blondell RD; Smith SJ; Servoss TJ; DeVaul SK; Simons RL
    J Addict Dis; 2007; 26(2):3-11. PubMed ID: 17594993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mandatory short-term methadone-to-abstinence program in New York City.
    Winick C
    Mt Sinai J Med; 2001 Jan; 68(1):41-5. PubMed ID: 11135505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
    Magura S; Lee JD; Hershberger J; Joseph H; Marsch L; Shropshire C; Rosenblum A
    Drug Alcohol Depend; 2009 Jan; 99(1-3):222-30. PubMed ID: 18930603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes toward methadone maintenance: implications for HIV prevention.
    Zule WA; Desmond DP
    J Psychoactive Drugs; 1998; 30(1):89-97. PubMed ID: 9565212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociodemographic disparities in supplemental service utilization among male methadone patients.
    Wu E; El-Bassel N; Gilbert L; Piff J; Sanders G
    J Subst Abuse Treat; 2004 Apr; 26(3):197-202. PubMed ID: 15063913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient maintenance/detoxification comparison of methadone and buprenorphine.
    Johnson RE; Fudala PJ; Collins CC; Jaffe JH
    NIDA Res Monogr; 1989; 95():384. PubMed ID: 2641003
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in locus-of-control attitudes about drug misuse in a self-help group in a methadone maintenance clinic.
    Nurco DN; Primm BJ; Lerner M; Stephenson P; Brown LS; Ajuluchukwu DC
    Int J Addict; 1995 May; 30(6):765-78. PubMed ID: 7657402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana use by methadone maintenance patients.
    Saxon AJ; Calsyn DA; Blaes PA; Haver VM; Greenberg DM
    NIDA Res Monogr; 1990; 105():306-7. PubMed ID: 1876021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.